Drug Shortage Report for GENOTROPIN
Report ID | 104764 |
Drug Identification Number | 02401762 |
Brand name | GENOTROPIN |
Common or Proper name | GENOTROPIN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SOMATROPIN |
Strength(s) | 0.6MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 7 PACK |
ATC code | H01AC |
ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-07-18 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2020-04-28 |
Shortage status | Avoided shortage |
Updated date | 2020-04-28 |
Company comments | Preventatively managing available supply through measured national allocation. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-04-28 | English | Compare |
v3 | 2020-02-29 | English | Compare |
v2 | 2020-01-29 | French | Compare |
v1 | 2020-01-29 | English | Compare |
Showing 1 to 4 of 4